Posted by Michael Wonder on 03 Jun 2019
No end in sight to rising drug prices, study finds
1 June 2019 - Researchers say bold bipartisan action is needed to stem the rising cost of popular prescription drugs that treat cancer, diabetes and other conditions.
The cost of many popular prescription drugs has increased substantially in the U.S. in the past six years, and the trend may continue if bold bipartisan action isn’t taken, according to a study published Friday.
The study, in the journal JAMA Network Open, found a substantial industry-wide rise in insurer and out-of-pocket costs for top-selling, brand-name prescription drugs, highlighting one of the foremost problems in health care today: unimpeded price increases in the pharmaceutical market.
